On December 11, 2023, Aditxt Inc. announced a merger agreement with Evofem Biosciences, which includes a $1.5 million investment in Evofem by April 7, 2025, and an extended merger deadline to September 30, 2025.
AI Assistant
ADITXT INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.